1st Quarter - Amendment

ALKERMES, INC. for ALKERMES, INC.

Period 1st Quarter 2013 Filed May 3, 2013 Signed by Kathryn Biberstein, SVP and General Counsel

Official filing
Firm
ALKERMES, INC.
Client
ALKERMES, INC.
Income
—
Expenses
$120,248
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 22, 2013 $92,883 Replaced
1st Quarter - Amendment (this page) May 3, 2013 $120,248 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discuss need for educational resources and status of Vivitrol in public health.

LobbyistCovered position, as disclosed
ROBERT FORMAN —

Contacted: HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Office of Natl Drug Control Policy (NDCP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.